Previous studies showed that allicin could reduce cerebral infarction areas, neuronal apoptosis, myeloperoxidase (MPO) activity, and tumor necrosis factor (TNF)‐α levels in serum to protect the brain from cerebral ischemia/reperfusion injury [7]. The gene discussed is MPO; the disease is brain ischemia.